Title Body Taxonomy Tags Year
Partek GS in Use at BC Cancer Agency

St. Louis, Missouri – August 25, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to the British Columbia Cancer Agency (BC Cancer Agency).


The BC Cancer Agency, which operates five cancer centers throughout Canada, will use Partek GS to analyze genomic data from cancer research studies. The Agency provides patient care, conducts cutting-edge cancer research, and advocates for prevention and early detection through community cancer screenings.


Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
The Munich Leukemia Laboratory Decides on Partek

St. Louis, Missouri – August 15, 2008 – The Munich Leukemia Laboratory (MLL) has purchased Partek® Genomics SuiteTM (Partek GS) software Partek Incorporated announced today.


Researchers at MLL will use Partek GS to analyze SNP data from research studies focused in Leukemia. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
The University of Glasgow Adopts Partek Genomics Suite

St. Louis, Missouri – August 12, 2008 – The University of Glasgow has purchased Partek® Genomics SuiteTM (Partek GS) software Partek Incorporated announced today.


Researchers within the Glasgow Cardiovascular Research Centre are using Partek GS to analyze gene expression data from studies in hypertension and stroke. The University was founded in 1451.


Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
The Newly Founded Institute for Regenerative Medicine at Texas A&M will Use Partek GS to Analyze Data

St. Louis, Missouri – August 8, 2008 – The Institute for Regenerative Medicine (IRM) at Texas A&M has purchased Partek® Genomics SuiteTM (Partek GS) software Partek Incorporated announced today.


Researchers at the Institute for Regenerative Medicine will use Partek GS to analyze stem cell research data. The IRM was founded in August 2008 and is researching ways to use adult stem cells to treat patient illnesses, such as diabetes, heart disease, and arthritis.


Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
UKM Medical Molecular Biology Institute Invests in Partek GS

St. Louis, Missouri – July 28, 2008 – The UKM Medical Molecular Biology Institute (UMBI) has purchased Partek® Genomics SuiteTM (Partek GS) software Partek Incorporated announced today.


Researchers at UMBI will use Partek GS to analyze genomic data. Research done at the Institute focuses on molecular medicine. UKM Medical Molecular Biology Institute is located in Malaysia.


Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
CSIRO Molecular & Health Technologies Analyzes Data in Partek

St. Louis, Missouri - July 25, 2008 - Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to CSIRO Molecular & Health Technologies (CSIRO).

CSIRO Molecular & Health Technologies will use Partek GS to analyze cancer gene expression data. CSIRO is a premier science organization with facilities all over the world.

Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
Partek GS Arrives at IGBMC

St. Louis, Missouri – July 24, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to the Institute of Genetics and Molecular and Cellular Biology (IGBMC).


IGBMC will use Partek GS to analyze genomic data. IGBMC, located in France, leads research in human pathology through genes and proteins.


Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
Partek Genomics Suite at Universite Catholique de Louvain

St. Louis, Missouri – July 23, 2008 – The Université Catholique de Louvain has purchased Partek® Genomics SuiteTM (Partek GS) software Partek Incorporated announced today.


Partek GS will be used in the rheumatology department to analyze genomic data. The University, which was founded in 1425, is located in Belgium.


Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
Partek GS Set-up at Peter MacCallum Cancer Centre

St. Louis, Missouri – July 18, 2008 – The Peter MacCallum Cancer Centre (Peter Mac) has purchased Partek® Genomics SuiteTM (Partek GS) software Partek Incorporated announced today.


Researchers at Peter Mac will use Partek GS software to analyze oncogenomic data. Peter Mac is a leading cancer organization that provides patient care, conducts educational programs, and conducts innovative research. The Centre is headquartered in East Melbourne, Victoria, Australia, but has campuses throughout Australia.


Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008
The Victorian AgriBiosciences Centre Relies on Partek

St. Louis, Missouri – July 16, 2008 – The Victorian AgriBiosciences Centre (VABC) has purchased Partek® Genomics SuiteTM (Partek GS) software Partek Incorporated announced today.


Researchers at VABC will use Partek GS to analyze genomic data. VABC, located in Australia, is a research division of LaTrobe University.


Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

2008

Pages